J9063 – Injection, mirvetuximab soravtansine-gynx, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9063
- Long description
- Injection, mirvetuximab soravtansine-gynx, 1 mg
- Short description
- Inj, elahere, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2023
- Last change
- July 1, 2023 – No change
Frequently asked questions
What is HCPCS code J9063?
J9063 is a HCPCS Level II code for injection, mirvetuximab soravtansine-gynx, 1 mg.
Does Medicare cover J9063?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9055 – Injection, cetuximab, 10 mg
- J9056 – Injection, bendamustine hydrochloride (vivimusta), 1 mg
- J9057 – Injection, copanlisib, 1 mg
- J9058 – Injection, bendamustine hydrochloride (apotex), 1 mg
- J9059 – Injection, bendamustine hydrochloride (baxter), 1 mg
- J9060 – Injection, cisplatin, powder or solution, 10 mg
- J9061 – Injection, amivantamab-vmjw, 2 mg
- J9062 – Injection, amivantamab 5 mg and hyaluronidase-lpuj
- J9064 – Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
- J9065 – Injection, cladribine, per 1 mg
- J9066 – Injection, bendamustine hydrochloride (avyxa), 1 mg
- J9070 – Cyclophosphamide, 100 mg
- J9071 – Injection, cyclophosphamide (auromedics), 5 mg
- J9072 – Injection, cyclophosphamide (frindovyx), 5 mg
- J9073 – Injection, cyclophosphamide (dr. reddy's), 5 mg
- J9074 – Injection, cyclophosphamide (sandoz), 5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.